Market Cap (In KRW)
3526.67 Billion
Revenue (In KRW)
34.14 Billion
Net Income (In KRW)
-73.7 Billion
Avg. Volume
870.91 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 46350.0-143600.0
- PE
- -
- EPS
- -
- Beta Value
- 0.974
- ISIN
- KR7141080002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yong Zu Kim
- Employee Count
- -
- Website
- https://www.legochembio.com
- Ipo Date
- 2013-05-10
- Details
- LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
More Stocks
-
HTZWW
-
034300
-
TTLTFTotal Telcom Inc.
TTLTF
-
NVI
-
DEF
-
603600UE Furniture Co., Ltd.
603600
-
DZRD
-
605199